We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Without Motive, Murder Hard To Prove In Meningitis Trials

Law360, New York (October 31, 2017, 7:01 PM EDT) -- Despite the dozens of deaths stemming from a 2012 meningitis outbreak linked to the New England Compounding Center and testimony about appalling conditions in its labs, federal prosecutors’ failure to secure murder convictions for its owner and head pharmacist boiled down to being unable to prove motive.

Two different federal juries reached largely the same results for pharmacist Glenn Chin and his boss Barry Cadden, head pharmacist and part owner of the now-closed NECC, convicting them of racketeering, mail fraud and other crimes, but clearing them of second-degree murder. While jurors in Cadden’s case seemingly came close to convicting him of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS